Name: UMIN ID:
Unique ID issued by UMIN | UMIN000001037 |
---|---|
Receipt number | R000001245 |
Scientific Title | Phase I/II Study of Topotecan and Ifosfamide in Pediatric Patients with Relapsed or Refractory Solid Tumors |
Date of disclosure of the study information | 2008/02/16 |
Last modified on | 2014/02/10 10:07:02 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2008/02/16 23:06:22 | ||
2 | Update | 2010/01/09 18:10:36 | UMIN ID1 |
|
3 | Update | 2010/01/09 18:28:14 | Organization Division name Division name Address Address TEL Homepage URL Organization Organization Division name Division name Address Address TEL Institute Co-sponsor Co-sponsor Organization1 Address1 Tel1 Email1 Organization2 Address2 Tel2 Email2 Institutions |
|
4 | Update | 2010/01/09 18:31:16 | Key inclusion criteria Key inclusion criteria |
|
5 | Update | 2010/01/27 09:31:15 | Recruitment status |
|
6 | Update | 2011/03/04 18:49:18 | Organization Division name Division name Division name Address Address TEL Address Address Organization1 Address1 Tel1 Email1 Institutions |
|
7 | Update | 2011/03/04 18:54:07 | Last follow-up date Publication of results URL related to results and publications Results Results |
|
8 | Update | 2011/03/16 10:34:16 | Email1 |
|
9 | Update | 2013/02/21 14:38:22 | Last name of lead principal investigator Last name of lead principal investigator Organization Organization Division name Division name Address Address TEL Address Address TEL Institute Institute Organization Organization Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
10 | Update | 2013/02/21 14:39:04 | Recruitment status |
|
11 | Update | 2013/09/17 08:01:59 | Email |
|
12 | Update | 2013/09/17 08:02:49 | Results |
|
13 | Update | 2014/02/10 10:01:33 | Recruitment status Last follow-up date Results |
|
14 | Update | 2014/02/10 10:07:02 | Organization Organization Division name Division name Address Address TEL Co-sponsor Co-sponsor |